Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility

Nathan, 1993, Long-term complications of diabetes mellitus, N Engl J Med, 328, 1676, 10.1056/NEJM199306103282306 Clark, 1995, Prevention and treatment of the complications of diabetes mellitus, N Engl J Med, 332, 1210, 10.1056/NEJM199505043321807 Timpl, 1989, Structure and activity of basement membrane proteins, Eur J Biochem, 180, 487, 10.1111/j.1432-1033.1989.tb14673.x Yurchenco, 1994, Assembly of laminin and type IV collagen in basement membrane networks, 351 1993 The Diabetes Control, Complications Trial Research Group, 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N Engl J Med, 329, 977, 10.1056/NEJM199309303291401 Brownlee, 1984, Nonenzymatic glycosylation and the pathogenesis of diabetic complications, Ann Intern Med, 101, 527, 10.7326/0003-4819-101-4-527 Ruderman, 1992, Glucose and diabetic vascular disease, FASEB J, 6, 2905, 10.1096/fasebj.6.11.1644256 Brownlee, 1995, Advanced protein glycosylation in diabetes and aging, Ann Rev Med, 46, 223, 10.1146/annurev.med.46.1.223 Vlassara, 1994, Pathogenic effects of advanced glycosylation: Biochemical, biologic, and clinical implications for diabetes and aging, Lab Invest, 70, 138 Daniels, 1992, Glycation of albumin, not glomerular basement membrane, alters permeability in an in vitro model, Diabetes, 41, 1415, 10.2337/diab.41.11.1415 Ziyadeh, 1993, Renal tubular basement membrane and collagen type IV in diabetes mellitus, Kidney Int, 43, 114, 10.1038/ki.1993.19 Cohen, 1996, Glycated albumin promotes a generalized vasculopathy in db/db mouse, Biochem Biophys Res Commun, 218, 72, 10.1006/bbrc.1996.0014 Cohen, 1996, Role of Amadori-modified nonenzymatically glycated serum proteins in the pathogenesis of diabetic nephropathy, J Am Soc Nephrol, 7, 183, 10.1681/ASN.V72183 Ziyadeh, 1997, Early and advanced nonenzymatic glycation products in the pathogenesis of diabetic kidney disease, Exp Nephrol, 5, 2 Reckelhoff JF, Tygart VL, Mitias MM, Walcott JL: STZ-induced diabetes results in decreased activity of glomerular cathepsin and metalloprotease in rats. Diabetes. 42: 1425–1432 Cohen, 1995, Albumin modified by Amadori glucose adducts activates mesangial cell type IV collagen gene transcription, Mol Cell Biochem, 151, 61, 10.1007/BF01076897 Kitamura, 1992, Gene expression of metallo-proteinase and its inhibitor in mesangial cells exposed to high glucose, Biochem Biophys Res Commun, 185, 1048, 10.1016/0006-291X(92)91732-6 Nakamura, 1994, Abnormal gene expression of matrix metalloproteinases and their inhibitor in glomeruli from diabetic rats, Ren Physiol Biochem, 17, 316 Shankland, 1996, Glomerular expression of tissue inhibitor of metalloproteinase (TIMP-1) in normal and diabetic rats, J Am Soc Nephrol, 7, 97, 10.1681/ASN.V7197 Anderson, 1996, Effect of matrix glycation on expression of type IV collagen, MMP-2, MMP-9 and TIMP-1 by human mesangial cells, Cell Adhesion Commun, 4, 89, 10.3109/15419069609010765 Hudson, 1993, Type IV collagen: Structure, gene organization, and role in human diseases, J Biol Chem, 268, 26033, 10.1016/S0021-9258(19)74270-7 Kahsai TZ, Enders GC, Gunwar S, Brunmark C, Wieslander J, Kalluri R, Zhou J, Noelken ME, Hudson BG: Seminiferous tubule basement membranes: Composition and organization of type IV collagen chains, and the linkage of 3(IV) and 5(IV) chains. J Biol Chem (in press) Timpl, 1981, A network model for the organization of type IV collagen molecules in basement membranes, Eur J Biochem, 120, 203, 10.1111/j.1432-1033.1981.tb05690.x Reiser, 1991, Nonenzymatic glycation of collagen in aging and diabetes, Proc Soc Exp Biol Med, 196, 17, 10.3181/00379727-196-43158C Reiser, 1992, Enzymatic and nonenzymatic cross-linking of collagen and elastin, FASEB J, 6, 2439, 10.1096/fasebj.6.7.1348714 Paul, 1996, Glycation of collagen: The basis of its central role in the late complications of ageing and diabetes, Int J Biochem Cell Biol, 28, 1297, 10.1016/S1357-2725(96)00079-9 Garlick, 1988, Nonenzymatic glycation of basement membranes from human glomeruli and bovine sources: Effects of diabetes and age, Diabetes, 37, 1144, 10.2337/diab.37.8.1144 Tsilibary, 1988, The effect of nonenzymatic glucosylation on the binding of the main noncollagenous NCI domain of type IV collagen, J Biol Chem, 263, 4302, 10.1016/S0021-9258(18)68925-2 Haitoglou, 1992, Altered cellular interactions between endothelial cells and nonenzymatically glucosylated laminin/type IV collagen, J Biol Chem, 267, 12404, 10.1016/S0021-9258(18)42287-9 Charonis, 1992, Structural and functional changes of laminin and type IV collagen after nonenzymatic glycation, Diabetes, 41, 49, 10.2337/diab.41.2.S49 Anderson, 1993, Nonenzymatic glycosylation-induced modifications of intact bovine kidney tubular basement membrane, J Clin Invest, 92, 3045, 10.1172/JCI116929 Bailey, 1993, Chemistry of collagen cross-links: Glucose-mediated covalent cross-linking of type IV collagen in lens capsules, Biochem J, 296, 489, 10.1042/bj2960489 Harding, 1985, Nonenzymatic covalent posttranslational modification of proteins in vivo, Adv Prot Chem, 37, 247 1989 Finot, 1990 Wells-Knecht, 1996, New biomarkers of Maillard reaction damage to proteins, Nephrol Dial Transplant, 11, 41, 10.1093/ndt/11.supp5.41 Baynes, 1991, Role of oxidative stress in development of complications in diabetes, Diabetes, 40, 405, 10.2337/diab.40.4.405 Baynes, 1995, Reactive oxygen in the aetiology and complications of diabetes, 2, 201 Sell, 1989, Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process, J Biol Chem, 264, 21597, 10.1016/S0021-9258(20)88225-8 Grandhee, 1991, Mechanism of formation of the Maillard protein cross-link pentosidine. Glucose, fructose and ascor-bate as pentosidine precursors, J Biol Chem, 266, 11649, 10.1016/S0021-9258(18)99006-X Dyer, 1991, Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo, J Biol Chem, 266, 11654, 10.1016/S0021-9258(18)99007-1 Ahmed, 1986, Identification of N-carboxym-ethyllysine as a degradation product of fructosyllysine in glycated protein, J Biol Chem, 261, 4889, 10.1016/S0021-9258(19)89188-3 Reddy, 1995, N-(Carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins, Biochemistry, 34, 10872, 10.1021/bi00034a021 Ikeda, 1996, N-(Carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction, Biochemistry, 35, 8075, 10.1021/bi9530550 Yang, 1994, Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease, Proc Natl Acad Sci USA, 91, 9436, 10.1073/pnas.91.20.9436 Lubec, 1980, Reduce susceptibility of nonenzymatically glucosylated glomerular basement membrane to proteases, Renal Physiol, 3, 4 Woessner, 1991, Matrix metalloproteinases and their inhibitors in connective tissue remodeling, FASEB J, 5, 2145, 10.1096/fasebj.5.8.1850705 Nagase, 1994, Matrix metalloproteinases. A mini-review, Contrib Nephrol, 107, 85, 10.1159/000422965 Nagase H: Matrix metalloproteinases, in Zinc Metalloproteases in Health and Disease, edited by, Hooper NM, London, Taylor & Francis (in press) Kefalides, 1985, Heterogeneity in basement membranes determines their structure and function, 73 Peczon, 1982, Probing the subunit structure of cow anterior lens capsule with the detergent, sodium dodecyl sulfate, Exp Eye Res, 35, 643, 10.1016/S0014-4835(82)80076-6 Freytag, 1976, Bovine renal glomerular basement membrane. Assessment of proteolysis during isolation, Biochem Biophys Res Commun, 72, 796, 10.1016/S0006-291X(76)80203-3 Spiro, 1967, Studies on renal glomerular basement membrane. Preparation and chemical composition, J Biol Chem, 242, 1915, 10.1016/S0021-9258(18)96088-6 Fox, 1981, Detergent-prepared glomerular basement membrane is composed of a heterogeneous group of polypeptides, J Biol Chem, 256, 9313, 10.1016/S0021-9258(19)52548-0 Reddy, 1993, Structure and composition of type IV collagen of bovine aorta, Biochim Biophys Acta, 1157, 241, 10.1016/0304-4165(93)90106-I Nagase, 1990, Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate, Biochemistry, 29, 5783, 10.1021/bi00476a020 Morodomi, 1992, Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells, Biochem J, 285, 603, 10.1042/bj2850603 Timoneda, 1990, Unusual dissociative behavior of the noncollagenous domain (hexamer) of basement membrane collagen during electro-phoresis and chromatofocusing, Connect Tissue Res, 24, 169, 10.3109/03008209009152147 Sell, 1989, Isolation, purification and partial characterization of novel fluorophores from aging human insoluble collagen-rich tissue, Connect Tissue Res, 19, 77, 10.3109/03008208909016816 Butkowski, 1985, Properties of the globular domain of type IV collagen and its relationship to the Goodpasture antigen, J Biol Chem, 260, 3739, 10.1016/S0021-9258(19)83686-4 Khalifah, 1996, Kinetics of nonenzymatic glycation of ribonuclease A leading to advanced glycation end products. Paradoxical inhibition by ribose leads to facile isolation of protein intermediate for rapid post-Amadori studies, Biochemistry, 35, 4645, 10.1021/bi9525942 Engvall, 1980, Enzyme immunoassay ELISA and EMIT, Meth Enzymol, 70, 419, 10.1016/S0076-6879(80)70067-8 Booth, 1997, In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways, J Biol Chem, 272, 5430, 10.1074/jbc.272.9.5430 Monnier, 1984, Accelerated age-related browning of human collagen in diabetes mellitus, Proc Natl Acad Sci USA, 81, 583, 10.1073/pnas.81.2.583 Odetti, 1996, Good glycaemic control reduces oxidation and glycation end-products in collagen of diabetic rats, Diabetologia, 39, 1440, 10.1007/s001250050596 Pongor, 1984, Aging of proteins: Isolation and identification of a fluorescent chromophore from the reaction of polypeptides with glucose, Proc Natl Acad Sci USA, 81, 2684, 10.1073/pnas.81.9.2684 Njoroge, 1988, Mechanism of formation of the putative advanced glycosylation end product and protein cross-link 2-(2-furoyl)-4(5)-(2-furanyl)-1H-imidazole, J Biol Chem, 263, 10646, 10.1016/S0021-9258(18)38020-7 Nagaraj, 1992, Isolation and characterization of a blue fluorophore from human eye lens crystallins: In vitro formation from Maillard reaction with ascorbate and ribose, Biochim Biophys Acta, 1116, 34, 10.1016/0304-4165(92)90125-E Ienaga, 1995, Crosslines, fluorophores in the AGE-related cross-linked proteins, Contrib Nephrol, 112, 42, 10.1159/000424091 Graham, 1996, A comprehensive survey of the acid-stable fluorescent cross-links formed by ribose with basic amino acids, and partial characterization of a novel Maillard cross-link, Biochim Biophys Acta, 1297, 9, 10.1016/0167-4838(96)00082-9 Nakamura, 1997, Acid-stable fluorescent advanced glycation end products: Vesperlysines A, B, and C are formed as crosslinked products in the Maillard reaction between lysine or proteins with glucose, Biochem Biophys Res Commun, 232, 227, 10.1006/bbrc.1997.6262 Bejarano, 1988, Degradation of basement membranes by human matrix metalloproteinase 3 (stromelysin), Biochem J, 256, 413, 10.1042/bj2560413 Murphy, 1989, Characterization of gelatinase from pig polymorphonuclear leucocytes. A metalloproteinase resembling tumour type IV collagenase, Biochem J, 258, 463, 10.1042/bj2580463 Wilhelm, 1989, SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages, J Biol Chem, 264, 17213, 10.1016/S0021-9258(18)71480-4 Nagase, 1996, Human matrix metalloproteinase specificity studies using collagen sequence-based synthetic peptides, Biopolymers, 40, 399, 10.1002/(SICI)1097-0282(1996)40:4<399::AID-BIP5>3.0.CO;2-R Matrisian, 1992, The matrix-degrading metalloproteinases, Bioessays, 14, 455, 10.1002/bies.950140705 Fessler, 1984, Characterization of the procollagen IV cleavage products produced by a specific tumor collagenase, J Biol Chem, 259, 9783, 10.1016/S0021-9258(17)42768-2 Raabe, 1996, Biochemical alterations in collagen IV induced by in vitro glycation, Biochem J, 319, 699, 10.1042/bj3190699 Schleicher, 1997, Increased accumulation of the glycoxidation product N-(carboxymethyl)lysine in human tissues in diabetes and aging, J Clin Invest, 99, 457, 10.1172/JCI119180 Muthukumaran, 1989, The complete primary structure for the alpha 1-chain of mouse collagen IV. Differential evolution of collagen IV domains, J Biol Chem, 264, 6310, 10.1016/S0021-9258(18)83349-X Hostikka, 1988, The complete primary structure of the alpha 2 chain of human type IV collagen and comparison with the alpha 1(IV) chain, J Biol Chem, 263, 19488, 10.1016/S0021-9258(19)77660-1 Pihlajaniemi, 1990, Complete primary structure of the triple-helical region and the carboxyl-terminal domain of a new type IV collagen chain, alpha 5(IV), J Biol Chem, 265, 13758, 10.1016/S0021-9258(18)77414-0